Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.

Aleksandra Antovic Annette BruchfeldJ EklandB LövströmA HugeliusO BörjessonA KnightI Gunnarsson

Published in: Scandinavian journal of rheumatology (2022)

Our findings highlight risks and suggest that more attention should be given to optimal AAV treatment in a pandemic situation. They also emphasize the need for continued shielding, mitigation strategies, and effective vaccination of AAV patients.

Keyphrases

end stage renal disease
sars cov
ejection fraction
newly diagnosed
coronavirus disease
chronic kidney disease
human health
combination therapy
patient reported outcomes